ERBB2 and breast cancer: There are two main metabolic phenotypes of breast cancer: the first depends mainly on glycolysis and the pentose phosphate pathway and is associated with low survival (most typical for HER2-positive and TNBC), the second—on fatty acid oxidation and glutaminolysis (typical for the luminal A subtype of breast cancer) [43].